Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


GUIDELINE TITLE

Glomerulonephritis.

BIBLIOGRAPHIC SOURCE(S)

  • Singapore Ministry of Health. Glomerulonephritis. Singapore: Singapore Ministry of Health; 2007 Mar. 130 p. [234 references]

REFERENCES SUPPORTING THE RECOMMENDATIONS

  • Al-Khader AA, Lien JW, Aber GM. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis. Clin Nephrol 1979 Jan;11(1):26-30. PubMed


  • Baker LR, Abrams L, Roe CJ, Faugere MC, Fanti P, Subayti Y, Malluche HH. 1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. Kidney Int 1989 Feb;35(2):661-9. [37 references] PubMed


  • Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 1991 Aug;36(2):53-9. PubMed


  • Beaufils H, Alphonse JC, Guedon J, Legrain M. Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. Nephron 1978;21(2):75-85. PubMed


  • Bianchi S, Bigazzi R, Caiazza A, Campese VM. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis 2003 Mar;41(3):565-70. PubMed


  • Black DA, Rose G, Brewer DB. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J 1970 Aug 22;3(5720):421-6.


  • Brossard JH, Lepage R, Cardinal H, Roy L, Rousseau L, Dorais C, D'amour P. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem 2000;46(5):697-703. PubMed


  • Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999 Dec;56(6):2220-6. PubMed


  • Cattran DC, Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 1994 Feb;23(2):247-54. PubMed


  • Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 1998 Jul;32(1):72-9. [45 references] PubMed


  • Cattran DC, Wang MM, Appel G, Matalon A, Briggs W. Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol 2004 Dec;62(6):405-11. PubMed


  • Cheong IK, Kong N, Segasothy M, Morad Z, Menon P, Suleiman AB. Asymptomatic proteinuria and/or haematuria in 265 Malaysian adults. Med J Malaysia 1991 Jun;46(2):150-4. PubMed


  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 Dec;42(6):1206-52. [386 references] PubMed


  • Choi MJ, Eustace JA, Gimenez LF, Atta MG, Scheel PJ, Sothinathan R, Briggs WA. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002 Mar;61(3):1098-114. PubMed


  • Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000 Jun;35(6 Suppl 2):S1-140. PubMed


  • Clinical practice guidelines: health screening - screening for renal disease. Singapore: Ministry of Health (MOH); 2003.  (Clinical practice guidelines; no. 6/2003).


  • Coburn JW, Maung HM. Use of active vitamin D sterols in patients with chronic kidney disease, stages 3 and 4. Kidney Int Suppl 2003 Jun;(85):S49-53. [22 references] PubMed


  • Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni M, Bonucci E, Taggi F. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study. Nephrol Dial Transplant 1996;11(5):813-9. PubMed


  • Cohen RA, Brown RS. Clinical practice. Microscopic hematuria. N Engl J Med 2003 Jun 5;348(23):2330-8. [42 references] PubMed


  • Combe C, Deforges-Lasseur C, Caix J, Pommereau A, Marot D, Aparicio M. Compliance and effects of nutritional treatment on progression and metabolic disorders of chronic renal failure. Nephrol Dial Transplant 1993;8(5):412-8. [104 references] PubMed


  • D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000 Aug;36(2):227-37. [64 references] PubMed


  • Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant 2002 Nov;17(11):2011-3. PubMed


  • Dillon JJ. Fish oil therapy for IgA nephropathy: efficacy and interstudy variability. J Am Soc Nephrol 1997 Nov;8(11):1739-44. PubMed


  • Donadio JV Jr, Larson TS, Bergstralh EJ, Grande JP. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol 2001 Apr;12(4):791-9. PubMed


  • Douglas JG, Agodoa L. ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial. Kidney Int Suppl 2003 Feb;(83):S74-6. PubMed


  • Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrol Dial Transplant 2004 Dec;19(12):3062-7. PubMed


  • Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR, et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 1989 Dec 15;111(12):992-1000. PubMed


  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 May 16;285(19):2486-97. PubMed


  • Floege J. Evidence-based recommendations for immunosuppression in IgA nephropathy: handle with caution. Nephrol Dial Transplant 2003 Feb;18(2):241-5. [27 references] PubMed


  • Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001 Jan;59(1):260-9. PubMed


  • Froom P, Ribak J, Benbassat J. Significance of microhaematuria in young adults. Br Med J (Clin Res Ed) 1984 Jan 7;288(6410):20-2. PubMed


  • Fujimoto S, Yamamoto Y, Hisanaga S, Morita S, Eto T, Tanaka K. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis 1991 Jun;17(6):687-92. PubMed


  • Georgopoulos M, Schuster FX, Porpaczy P, Schramek P. Evaluation of asymptomatic microscopic haematuria--influence and clinical relevance of osmolality and pH on urinary erythrocyte morphology. Br J Urol 1996 Aug;78(2):192-6. PubMed


  • Ghiggeri GM, Catarsi P, Scolari F, Caridi G, Bertelli R, Carrea A, Sanna-Cherchi S, Emma F, Allegri L, Cancarini G, Rizzoni GF, Perfumo F. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study. Clin Ther 2004 Sep;26(9):1411-8. PubMed


  • Glassock RJ. The treatment of IgA nephropathy: status at the end of the millenium. J Nephrol 1999 Sep-Oct;12(5):288-96. [70 references] PubMed


  • Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000 May 18;342(20):1478-83. PubMed


  • Grossfeld GD, Wolf JS Jr, Litwan MS, Hricak H, Shuler CL, Agerter DC, Carroll PR. Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am Fam Physician 2001 Mar 15;63(6):1145-54. [38 references] PubMed


  • Habib R, Niaudet P. Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis. Clin Nephrol 1994;42(3):141-6. PubMed


  • Herlitz H, Harris K, Risler T, Boner G, Bernheim J, Chanard J, Aurell M. The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study. Nephrol Dial Transplant 2001 Nov;16(11):2158-65. PubMed


  • Imbasciati E, Gusmano R, Edefonti A, Zucchelli P, Pozzi C, Grassi C, Della Volpe M, Perfumo F, Petrone P, Picca M, et al.. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. Br Med J (Clin Res Ed) 1985 Nov 9;291(6505):1305-8. PubMed


  • Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Clin Nephrol 1995 Sep;44(3):156-62. PubMed


  • Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS, AIPRD Study Group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003 Aug 19;139(4):244-52.


  • Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS, AIPRD Study Group. Angiotensin-Converting Enzymne Inhibition and Progression of. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 2001 Sep;60(3):1131-40. PubMed


  • Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha B, Man NK. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 1997;12(12):2597-602. PubMed


  • K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002 Feb;39(2 Suppl 2):S1-246. PubMed


  • K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003 Apr;41(4 Suppl 3):I-IV, S1-91. PubMed


  • K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004 May;43(5 Suppl 1):S1-290. [625 references] PubMed


  • Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT. Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transplant 2004 Jul;19(7):1808-14. PubMed


  • Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000 Feb;163(2):524-7. PubMed


  • Kincaid-Smith P, Fairley K. The investigation of hematuria. Semin Nephrol 2005 May;25(3):127-35. [43 references] PubMed


  • Klahr S. Prevention of progression of nephropathy. Nephrol Dial Transplant 1997;12 Suppl 2:63-6. [24 references] PubMed


  • Korbet SM, Schwartz MM, Lewis EJ. Minimal-change glomerulopathy of adulthood. Am J Nephrol 1988;8(4):291-7. PubMed


  • Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int 2002 Dec;62(6):2301-10. PubMed


  • Lai KN, Lai FM, Ho CP, Chan KW. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin Nephrol 1986 Oct;26(4):174-80. PubMed


  • Lee G, Glassock R. Immunoglobulin A nephropathy. In: Ronticelli C, Glassock RJ, editor(s). Treatment of glomerulonephritis. Oxford: Oxford Medical Publications; 1997. p. 186-217.


  • Lee GS, Choong HL, Chiang GS, Woo KT. Three-year randomized controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephropathy and renal impairment. Nephrology 1997;3(1):117-21.


  • Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. Am J Kidney Dis 2006 May;47(5):751-60. PubMed


  • Lim CH, Woo KT, Chiang GS. Correlation of proteinuria with histopathology in asymptomatic glomerulonephritis. Ann Acad Med Singapore 1982 Jan;11(1):9-14. PubMed


  • Macdougall IC, Tucker B, Thompson J, Tomson CR, Baker LR, Raine AE. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 1996 Nov;50(5):1694-9. [111 references] PubMed


  • Mak SK, Short CD, Mallick NP. Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Transplant 1996 Nov;11(11):2192-201. PubMed


  • Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol 1989 Feb;141(2):350-5. PubMed


  • Martinelli R, Pereira LJ, Silva OM, Okumura AS, Rocha H. Cyclophosphamide in the treatment of focal segmental glomerulosclerosis. Braz J Med Biol Res 2004 Sep;37(9):1365-72. PubMed


  • Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, Sasdelli M, Zuccala A, Zucchelli P. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant 1994;9(3):265-9. PubMed


  • Matsumoto H, Nakao T, Okada T, Nagaoka Y, Takeguchi F, Tomaru R, Iwasawa H. Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome. Intern Med 2004 Aug;43(8):668-73. PubMed


  • Melocoton TL, Kamil ES, Cohen AH, Fine RN. Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 1991 Nov;18(5):583-8. PubMed


  • Meyrier A, Noel LH, Auriche P, Callard P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int 1994 May;45(5):1446-56. PubMed


  • Meyrier A. Treatment of idiopathic nephrosis by immunophillin modulation. Nephrol Dial Transplant 2003 Aug;18 Suppl 6:vi79-86. [36 references] PubMed


  • Meyrier A. Treatment of idiopathic nephrotic syndrome with cyclosporine A. J Nephrol 1997 Jan-Feb;10(1):14-24. [76 references] PubMed


  • Mora-Macia J, Cases A, Calero F, Barcelo P. Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure. Nephrol Dial Transplant 2001;16 Suppl 1:82-4. PubMed


  • Nagai R, Cattran DC, Pei Y. Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly. Clin Nephrol 1994 Jul;42(1):18-21. PubMed


  • Nair RB, Date A, Kirubakaran MG, Shastry JC. Minimal-change nephrotic syndrome in adults treated with alternate-day steroids. Nephron 1987;47(3):209-10. PubMed


  • Nakamura T, Ushiyama C, Hirokawa K, Osada S, Inoue T, Shimada N, Koide H. Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis. Nephrol Dial Transplant 2002 May;17(5):798-802. PubMed


  • Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 2003 Jan 11;361(9352):117-24. PubMed


  • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003 Oct;42(4 Suppl 3):S1-201. [664 references] PubMed


  • NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001 Jan;37(1 Suppl 1):S182-238. PubMed


  • Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int 1986 Jun;29(6):1215-23. PubMed


  • Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. Am J Med 1987 May;82(5):938-44. PubMed


  • Pendse S, Ginsburg E, Singh AK. Strategies for preservation of ovarian and testicular function after immunosuppression. Am J Kidney Dis 2004 May;43(5):772-81. [94 references] PubMed


  • Pesavento TE, Bay WH, Agarwal G, Hernandez RA Jr, Hebert LA. Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy. Am J Kidney Dis 2004 Mar;43(3):e3-6. PubMed


  • Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P, et al.. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 1993;8(12):1326-32. PubMed


  • Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F, et al.. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993 Jun;43(6):1377-84. PubMed


  • Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, Passerini P, Farina M, Grassi C, Baroli A. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis. Am J Kidney Dis 1999 Oct;34(4):618-25. PubMed


  • Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, Locatelli F. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 1999 Mar 13;353(9156):883-7. PubMed


  • Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol 2003 Jun;14(6):1578-83. PubMed


  • Praga M, Gutierrez-Millet V, Navas JJ, Ruilope LM, Morales JM, Alcazar JM, Bello I, Rodicio JL. Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy. Kidney Int 1985 Jul;28(1):69-74. PubMed


  • Pritchard NR, Milford DV, O'Donoghue DJ. Cyclosporin A therapy in frequently relapsing nephrotic syndrome and IgA nephropathy. Nephrol Dial Transplant 1997 Nov;12(11):2402-4. PubMed


  • Radhakrishnan J, Wang M, Matalon A. Mycophenolate mofetil (MMF) treatment of idiopathic focal segmental glomerular sclerosis (FSGS). In: American Society of Nephrologists Annual Scientific Meeting; Miami.1999.


  • Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T, ALLHAT Collaborative Research Group. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006 Feb 7;144(3):172-80. PubMed


  • Remuzzi A, Perico N, Sangalli F, Vendramin G, Moriggi M, Ruggenenti P, Remuzzi G. ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy. Am J Physiol 1999 Mar;276(3 Pt 2):F457-66. PubMed


  • Robinson RR. Isolated proteinuria in asymptomatic patients. Kidney Int 1980 Sep;18(3):395-406. PubMed


  • Ruggenenti P, Perna A, Remuzzi G, GISEN Group Investigators. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int 2003 Jun;63(6):2254-61. PubMed


  • Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 2001 Jul;38(1):18-25. PubMed


  • Rydel JJ, Korbet SM, Borok RZ, Schwartz MM. Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis 1995 Apr;25(4):534-42. PubMed


  • Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Immunosuppressive agents for treating IgA nephropathy (Cochrane Review). In: The Renal Health Library. Oxford: Update Software Ltd.; 2005 


  • Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology 2004 Aug;9(4):177-85. PubMed


  • Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med 2005 Mar 1;142(5):342-51. PubMed


  • Schena FP, Montenegro M, Scivittaro V. Meta-analysis of randomised controlled trials in patients with primary IgA nephropathy (Berger's disease). Nephrol Dial Transplant 1990;5 Suppl 1:47-52. PubMed


  • Schieppati A, Perna A, Zamora J, Giuliano GA, Braun N, Remuzzi G. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev 2004;(4):CD004293. [58 references] PubMed


  • Schramek P, Schuster FX, Georgopoulos M, Porpaczy P, Maier M. Value of urinary erythrocyte morphology in assessment of symptomless microhaematuria. Lancet 1989 Dec 2;2(8675):1316-9. PubMed


  • Scottish Intercollegiate Guidelines Network (SIGN). Investigations of asymptomatic proteinuria in adults: a quick reference guide. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1997. 19 p.


  • Segarra A, Vila J, Pou L, Majo J, Arbos A, Quiles T, Piera LL. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 2002 Apr;17(4):655-62. PubMed


  • Shiiki H, Nishino T, Uyama H, Kimura T, Nishimoto K, Iwano M, Kanauchi M, Fujii Y, Dohi K. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS). Clin Nephrol 1996 Dec;46(6):362-8. PubMed


  • Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR. Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study. Ann Intern Med 1982 Oct;97(4):516-9. PubMed


  • Stenvinkel P, Alvestrand A, Bergstrom J. Factors influencing progression in patients with chronic renal failure. J Intern Med 1989 Sep;226(3):183-8. PubMed


  • Stirling CM, Mathieson P, Boulton-Jones JM, Feehally J, Jayne D, Murray HM, Adu D. Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM 2005 Jun;98(6):443-9. PubMed


  • Strippoli GF, Craig JC, Manno C, Schena FP. Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2004 Dec;15(12):3154-65. PubMed


  • Sultana SR, Goodman CM, Byrne DJ, Baxby K. Microscopic haematuria: urological investigation using a standard protocol. Br J Urol 1996 Nov;78(5):691-6; discussion 697-8. PubMed


  • Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001 Apr 15;110(6):434-7. PubMed


  • Tang S, Tang AW, Tam MK, Ho YW. Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome. Am J Kidney Dis 2003 Nov;42(5):E13-5. PubMed


  • The third report of the Singapore Renal Registry 1999/2000. Singapore: National Disease Registry Office (NDRO); 1999. 82 p.


  • Tsukamoto Y, Moriya R, Nagaba Y, Morishita T, Izumida I, Okubo M. Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure. Am J Kidney Dis 1995 Jun;25(6):879-86. PubMed


  • Vrecer M, Turk S, Drinovec J, Mrhar A. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials. Int J Clin Pharmacol Ther 2003 Dec;41(12):567-77. PubMed


  • Wang F, Looi LM, Chua CT. Minimal change glomerular disease in Malaysian adults and use of alternate day steroid therapy. Q J Med 1982 Summer;51(203):312-28. PubMed


  • Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004 May;15(5):1307-15. PubMed


  • Widmer B, Gerhardt RE, Harrington JT, Cohen JJ. Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure. Arch Intern Med 1979 Oct;139(10):1099-102. PubMed


  • Woo KT, Chiang GS, Edmondson RP, Wu AY, Lee EJ, Pwee HS, Lim CH. Glomerulonephritis in Singapore: an overview. Ann Acad Med Singapore 1986 Jan;15(1):20-31. PubMed


  • Woo KT, Lau YK, Wong KS, Chiang GS. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis. Kidney Int 2000 Dec;58(6):2485-91. PubMed


  • Woo KT, Lau YK, Wong KS, Lee GS, Chin YM, Chiang GS, Lim CH. Isoelectric focusing and selectivity index in IgA nephrotic syndrome. Nephron 1994;67(4):408-13. PubMed


  • Woolhandler S, Pels RJ, Bor DH, Himmelstein DU, Lawrence RS. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. JAMA 1989 Sep 1;262(9):1214-9. [58 references] PubMed


  • Yamagata K, Yamagata Y, Kobayashi M, Koyama A. A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol 1996 May;45(5):281-8. PubMed


  • Yip SK, Peh WC, Tam PC, Li JH, Lam CH. Day case hematuria diagnostic service: use of ultrasonography and flexible cystoscopy. Urology 1998 Nov;52(5):762-6. PubMed


  • Yip SK, Peh WC, Tam PC, Li JH, Lam CH. Role of ultrasonography in screening for urological malignancies in patients presenting with painless haematuria. Ann Acad Med Singapore 1999 Mar;28(2):174-7. PubMed


  • Yun EJ, Meng MV, Carroll PR. Evaluation of the patient with hematuria. Med Clin North Am 2004 Mar;88(2):329-43. [49 references] PubMed


© 1998-2009 National Guideline Clearinghouse

Date Modified: 2/9/2009

 

 

   
DHHS Logo